Ameriprise’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,811
| Closed | -$2.78M | – | 4032 |
|
|
2021
Q1 | $2.78M | Sell |
12,811
-103,948
| -89% | -$19.5M | ﹤0.01% | 2723 |
|
|
2020
Q4 | $13.5M | Buy |
116,759
+2,238
| +2% | +$251K | ﹤0.01% | 1523 |
|
|
2020
Q3 | $11.2M | Sell |
114,521
-4,623
| -4% | -$532K | ﹤0.01% | 1483 |
|
|
2020
Q2 | $14.6M | Buy |
119,144
+25,105
| +27% | +$2.85M | 0.01% | 1262 |
|
|
2020
Q1 | $8.23M | Buy |
94,039
+12,109
| +15% | +$1.28M | ﹤0.01% | 1538 |
|
|
2019
Q4 | $8.56M | Sell |
81,930
-182,563
| -69% | -$20.5M | ﹤0.01% | 1868 |
|
|
2019
Q3 | $30.4M | Sell |
264,493
-39,033
| -13% | -$5.92M | 0.01% | 880 |
|
|
2019
Q2 | $52.3M | Sell |
303,526
-91,017
| -23% | -$15.7M | 0.02% | 653 |
|
|
2019
Q1 | $66.5M | Sell |
394,543
-798
| -0.2% | -$119K | 0.03% | 544 |
|
|
2018
Q4 | $38.4M | Buy |
395,341
+339,042
| +602% | +$44.5M | 0.02% | 721 |
|
|
2018
Q3 | $9.73M | Sell |
56,299
-4,408
| -7% | -$636K | ﹤0.01% | 1884 |
|
|
2018
Q2 | $8.45M | Buy |
60,707
+20,660
| +52% | +$2.93M | ﹤0.01% | 1874 |
|
|
2018
Q1 | $4.51M | Buy |
40,047
+13,491
| +51% | +$1.7M | ﹤0.01% | 2245 |
|
|
2017
Q4 | $3.51M | Buy |
26,556
+765
| +3% | +$89.9K | ﹤0.01% | 2355 |
|
|
2017
Q3 | $2.62M | Buy |
25,791
+23,727
| +1,150% | +$2.54M | ﹤0.01% | 2467 |
|
|
2017
Q2 | $207K | Buy |
2,064
+162
| +9% | +$17.4K | ﹤0.01% | 3553 |
|
|
2017
Q1 | $230K | Buy |
+1,902
| New | +$233K | ﹤0.01% | 3438 |
|
|
2016
Q4 | – | Sell |
-9,716
| Closed | -$1.29M | – | 3976 |
|
|
2016
Q3 | $1.29M | Sell |
9,716
-7,050
| -42% | -$674K | ﹤0.01% | 2804 |
|
|
2016
Q2 | $1.54M | Sell |
16,766
-5,161
| -24% | -$434K | ﹤0.01% | 2657 |
|
|
2016
Q1 | $1.58M | Sell |
21,927
-34,553
| -61% | -$1.9M | ﹤0.01% | 2635 |
|
|
2015
Q4 | $3.92M | Buy |
56,480
+28,288
| +100% | +$2.3M | ﹤0.01% | 2206 |
|
|
2015
Q3 | $2.58M | Sell |
28,192
-1,001
| -3% | -$111K | ﹤0.01% | 2473 |
|
|
2015
Q2 | $3.59M | Buy |
+29,193
| New | +$3.31M | ﹤0.01% | 2365 |
|
|
2014
Q4 | – | Sell |
-217
| Closed | -$17K | – | 4626 |
|
|
2014
Q3 | $17K | Buy |
217
+70
| +48% | +$6.19K | ﹤0.01% | 4562 |
|
|
2014
Q2 | $15K | Buy |
147
+54
| +58% | +$3.75K | ﹤0.01% | 4482 |
|
|
2014
Q1 | $6K | Buy |
+93
| New | +$5.53K | ﹤0.01% | 4745 |
|
Other funds holding GWPH
Ameriprise's GWPH Position: Q2 2021 in Review
Ameriprise sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 12,811 shares — an estimated $2.78M sold.
Ameriprise first reported a position in GWPH in Q1 2014 and held it in 26 quarters. The position peaked at $66.5M in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Ameriprise reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Ameriprise sold 12,811 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.78M.
- Ameriprise first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 26 quarters.
- Ameriprise's GW Pharmaceuticals Plc American Depositary Shares position peaked at $66.5M in Q1 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.